Hearing Leerink Swan Positive on Bio Sante, $6 Target Price

@markflowchatter reports that Leerink Swan has released another positive report on Bio Sante BPAX.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorNewsRumorsBiotechnologyHealth CareLeerink Swan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!